Market capitalization | $21.70b |
Enterprise Value | $24.89b |
PER (TTM) P/E ratio | 57.66 |
EV/FCF (TTM) EV/FCF | 40.61 |
EV/Sales (TTM) EV/Sales | 4.57 |
P/S ratio (TTM) P/S ratio | 3.99 |
P/B ratio (TTM) P/B ratio | 3.44 |
Dividend yield | 0.92% |
Last dividend (FY24) | $2.03 |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
9 Analysts have issued a Steris forecast:
9 Analysts have issued a Steris forecast:
Mar '24 |
+/-
%
|
||
Net profit | 378 378 |
253%
253%
|
|
Depreciation and amortization | 565 565 |
2%
2%
|
|
Share compensation | 57 57 |
45%
45%
|
|
Operating cash flow | 973 973 |
29%
29%
|
|
Investments | 360 360 |
0%
0%
|
|
Dividend paid | 201 201 |
9%
9%
|
|
Free cash flow | 613 613 |
55%
55%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
STERIS Plc (Ireland) engages in the manufacture of medical and surgical equipment. The company was founded on December 22, 2016 and is headquartered in Dublin, Ireland.
Head office | Ireland |
CEO | Daniel Carestio |
Employees | 18,179 |
Founded | 2016 |
Website | www.steris.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.